Company Website
Contact information Josh Gariboldi, PharmD, BCPS Joshua.Gariboldi@otsuka-us.com 9542708392 Rim Hadgu, PharmD, BCPS Rim.Hadgu@otsuka-us.com 3142959699 | Virtual Exhibit Hall Home NephU is an engaged community of health care professionals and advocates collaborating to improve kidney health. Through increased awareness, collaboration, and information-sharing, our mission is to improve the future outcomes for individuals with kidney disease and other related conditions.
Understanding IgAN pathogenesis, progression, and management is critical for improving IgAN patient care. NephU has gathered expert-led resources and webinars to encourage ongoing disease education. Visit our Resource Center for more information.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI. Additional Information:
Risk of Progression to ESKD in IgA Nephropathy APRIL and the Four Hit Pathogenic Cascade in IgA Nephropathy |